£68.52

Elsevier Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America (Volume 34-2) (The Clinics: Internal Medicine, Volume 34-2)

Price data last checked 104 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£69 today · previous high £69 · all-time low £68

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 627 days • 627 data points (No recent data available)

Historical
Generating forecast...
£68.52 £67.62 £67.81 £68.01 £68.21 £68.41 £68.60 10 June 2024 13 November 2024 19 April 2025 22 September 2025 26 February 2026

Price Distribution

Price distribution over 627 days • 1 price levels

Days at Price
627 days 0 157 314 470 627 £68 Days at Price

Price Analysis

Most common price: £68 (627 days, 100.0%)

Price range: £68 - £68

Price levels: 1 different prices over 627 days

Description

This issue of Hematology/Oncology Clinics, guest edited by David P. Steensma, will cover key topics in Myelodysplastic Syndromes. This issue is one of six selected each year by our series consulting editors, George P. Canellos and Edward J. Benz. Topics discussed in this issue will include: Novel prognostic models for MDS, Evaluating MDS patients with genetic mutations that might be germline, Implications of splicing mutations in MDS for pathophysiology and therapy, Assessing quality of life in MDS/MPN overlap patients, Creation of a clinic for patients with clonal hematopoiesis, Luspatercept in MDS, Prospects for venetoclax in MDS, Treatment of acquired sideroblastic anemias, Treatment of patients with AML arising from MDS, Targeting TP53 mutations in MDS, among others.

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
08 March 2020
Listed Since
27 September 2019

Barcode

No barcode data available

Similar Products You Might Like

Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)
98% match

Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)

Elsevier

£71.63 26 Feb 2026
MYELODYSPLASTIC SYNDROMES: From Pathogenesis to Diagnosis & Therapy (Recent Advances in Hematology Research)
98% match

MYELODYSPLASTIC SYNDROMES: From Pathogenesis to Diagnosis & Therapy (Recent Advances in Hematology Research)

£104.18 13 Jan 2026
Myelodysplastic Syndromes: Pathobiology and Clinical Management: 36 (Basic and Clinical Oncology)
98% match

Myelodysplastic Syndromes: Pathobiology and Clinical Management: 36 (Basic and Clinical Oncology)

CRC Press

£142.02 02 Mar 2026
Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)
97% match

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)

Elsevier

£71.63 27 Feb 2026
Bone Marrow Failure, An Issue of Hematology/Oncology Clinics of North America (Volume 32-4) (The Clinics: Internal Medicine, Volume 32-4)
97% match

Bone Marrow Failure, An Issue of Hematology/Oncology Clinics of North America (Volume 32-4) (The Clinics: Internal Medicine, Volume 32-4)

Elsevier

£68.52 01 Mar 2026
Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)
97% match

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)

Springer

£110.29 12 Dec 2025
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
97% match

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Springer

£92.42 08 Jan 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
97% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

£116.62 13 Jan 2026
Acute Myeloid Leukemia (Hematologic Malignancies)
97% match

Acute Myeloid Leukemia (Hematologic Malignancies)

£92.25 08 Jan 2026
The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America (Volume 31-4) (The Clinics: Internal Medicine, Volume 31-4)
97% match

The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America (Volume 31-4) (The Clinics: Internal Medicine, Volume 31-4)

Elsevier

£68.41 08 Mar 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
97% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Springer

£122.70 07 Mar 2026
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
97% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£96.51 12 Apr 2026
Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)
97% match

Myeloproliferative Neoplasms: Biology and Therapy (Contemporary Hematology)

Humana

£79.98 13 Jan 2026
Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America (Volume 26-5) (The Clinics: Internal Medicine, Volume 26-5)
97% match

Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America (Volume 26-5) (The Clinics: Internal Medicine, Volume 26-5)

Saunders

£53.59 11 Apr 2026
Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)
96% match

Minimal Residual Disease in Acute Leukemia 1986: 45 (Developments in Oncology, 45)

Springer

£179.96 27 Jan 2026
Molecular Hematology
96% match

Molecular Hematology

Wiley-Blackwell

£128.43 25 Feb 2026
Myeloproliferative Disorders (Hematologic Malignancies)
96% match

Myeloproliferative Disorders (Hematologic Malignancies)

Springer

£94.99 21 Feb 2026
Myelodysplastic Syndromes (Hematologic Malignancies)
96% match

Myelodysplastic Syndromes (Hematologic Malignancies)

Springer

£86.02 04 Mar 2026
Acute Myelogenous Leukemia (Contemporary Hematology)
96% match

Acute Myelogenous Leukemia (Contemporary Hematology)

Humana

£164.16 09 Jan 2026
Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)
96% match

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Humana

£84.99 17 Mar 2026
CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)
96% match

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

£113.67 09 Jan 2026
Managing Myeloproliferative Neoplasms: A Case-Based Approach
96% match

Managing Myeloproliferative Neoplasms: A Case-Based Approach

Cambridge University Press

£52.33 08 Mar 2026
Leukemia and Related Disorders: Integrated Treatment Approaches (Contemporary Hematology)
96% match

Leukemia and Related Disorders: Integrated Treatment Approaches (Contemporary Hematology)

Humana

£79.98 22 Jan 2026
Oxford Specialist Handbook: Myeloproliferative Neoplasms (Oxford Specialist Handbooks in Oncology)
96% match

Oxford Specialist Handbook: Myeloproliferative Neoplasms (Oxford Specialist Handbooks in Oncology)

Oxford University Press

£68.99 01 Mar 2026